Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 117

1.

Dietary determinants of plasma homocysteine concentrations.

Verhoef P, de Groot LC.

Semin Vasc Med. 2005 May;5(2):110-23. Review.

PMID:
16047264
2.

Efficacy of folate and vitamin B12 in lowering homocysteine concentrations in hemodialysis patients.

Azadibakhsh N, Hosseini RS, Atabak S, Nateghiyan N, Golestan B, Rad AH.

Saudi J Kidney Dis Transpl. 2009 Sep;20(5):779-88.

3.

Determinants of fasting and post-methionine homocysteine levels in families predisposed to hyperhomocysteinemia and premature vascular disease.

de Jong SC, Stehouwer CD, van den Berg M, Kostense PJ, Alders D, Jakobs C, Pals G, Rauwerda JA.

Arterioscler Thromb Vasc Biol. 1999 May;19(5):1316-24.

4.

Effects of folic acid fortification and multivitamin therapy on homocysteine and vitamin B(12) status in cardiac transplant recipients.

Miriuka SG, Langman LJ, Keren ES, Miner SE, Mamer OA, Delgado DH, Evrovski J, Ross HJ, Cole DE.

J Heart Lung Transplant. 2004 Apr;23(4):405-12.

PMID:
15063399
5.
6.

Hyperhomocysteinemia in hemodialysis patients: effects of 12-month supplementation with hydrosoluble vitamins.

Tremblay R, Bonnardeaux A, Geadah D, Busque L, Lebrun M, Ouimet D, Leblanc M.

Kidney Int. 2000 Aug;58(2):851-8.

7.

Dietary strategies for lowering homocysteine concentrations.

Riddell LJ, Chisholm A, Williams S, Mann JI.

Am J Clin Nutr. 2000 Jun;71(6):1448-54.

8.

Homocysteine in chronic kidney disease: Effect of low protein diet and repletion with B vitamins.

Menon V, Wang X, Greene T, Beck GJ, Kusek JW, Selhub J, Levey AS, Sarnak MJ.

Kidney Int. 2005 Apr;67(4):1539-46.

9.

Hyperhomocysteinaemia, folate and vitamin B12 in unsupplemented haemodialysis patients: effect of oral therapy with folic acid and vitamin B12.

Billion S, Tribout B, Cadet E, Queinnec C, Rochette J, Wheatley P, Bataille P.

Nephrol Dial Transplant. 2002 Mar;17(3):455-61.

PMID:
11865092
10.

Efficacy of B vitamins in lowering homocysteine in older men: maximal effects for those with B12 deficiency and hyperhomocysteinemia.

Flicker L, Vasikaran SD, Thomas J, Acres JM, Norman P, Jamrozik K, Hankey GJ, Almeida OP.

Stroke. 2006 Feb;37(2):547-9. Epub 2005 Dec 22.

11.

Clinical use and rational management of homocysteine, folic acid, and B vitamins in cardiovascular and thrombotic diseases.

Stanger O, Herrmann W, Pietrzik K, Fowler B, Geisel J, Dierkes J, Weger M.

Z Kardiol. 2004 Jun;93(6):439-53. Review.

PMID:
15252738
13.

Homocysteine concentrations in adults with trisomy 21: effect of B vitamins and genetic polymorphisms.

Fillon-Emery N, Chango A, Mircher C, Barbé F, Bléhaut H, Herbeth B, Rosenblatt DS, Réthoré MO, Lambert D, Nicolas JP.

Am J Clin Nutr. 2004 Dec;80(6):1551-7.

14.

Plasma homocysteine after insulin infusion in type II diabetic patients with and without methionine intolerance.

Ventura P, Panini R, Emiliani S, Salvioli G.

Exp Clin Endocrinol Diabetes. 2004 Jan;112(1):44-51.

PMID:
14758571
15.

[Hyperhomocysteinemia and alternate vitamin supplementation].

De Angelis S, Noce A, Dessì M, Pastore A, Scaccia F, Trombetta M, Tozzo C, Splendiani G.

G Ital Nefrol. 2007 Jan-Feb;24(1):51-5. Italian.

PMID:
17342693
16.

Changes in basal and postmethionine load concentrations of total homocysteine and cystathionine after B vitamin intervention.

Bleie Ø, Refsum H, Ueland PM, Vollset SE, Guttormsen AB, Nexo E, Schneede J, Nordrehaug JE, Nygård O.

Am J Clin Nutr. 2004 Sep;80(3):641-8.

17.

Homocysteine and risk of cardiovascular disease.

Andreotti F, Burzotta F, Manzoli A, Robinson K.

J Thromb Thrombolysis. 2000 Jan;9(1):13-21. Review.

PMID:
10590184
19.

Homocysteine-lowering vitamins do not lower plasma S-adenosylhomocysteine in older people with elevated homocysteine concentrations.

Green TJ, Skeaff CM, McMahon JA, Venn BJ, Williams SM, Devlin AM, Innis SM.

Br J Nutr. 2010 Jun;103(11):1629-34. doi: 10.1017/S0007114509993552. Epub 2010 Jan 21.

PMID:
20089204
20.

Controlled trials of very high dose folic acid, vitamins B12 and B6, intravenous folinic acid and serine for treatment of hyperhomocysteinemia in ESRD.

Gonin JM, Nguyen H, Gonin R, Sarna A, Michels A, Masri-Imad F, Bommareddy G, Chassaing C, Wainer I, Loya A, Cary D, Barker LF, Assefi A, Greenspan R, Mahoney D, Wilcox CS.

J Nephrol. 2003 Jul-Aug;16(4):522-34.

PMID:
14696754

Supplemental Content

Support Center